
Merck scores at FDA as Lipfendra becomes world's first oral PCSK9 treatment
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxNRHZYVFhPOHA1UklyQmxaQ3ZaZ0hQc2Y2QVRIN24tWHBfMklpVkljOE9GeDlXdTJkUksyekx5SVNERHljVlVCeGVvdkZ4MF9lbDUycWpyeGR4aTBnaHFVWjRuTFdQTWR5QlhNNWVPSmlrYjRILWRXMlRpNWphbkUwM1FqTTlDZE1ra0NLRTF2cXpYUEdlRDVRZHZfZjIyaTVQUl9B?oc=5" target="_blank">Merck scores at FDA as Lipfendra becomes world's first oral PCSK9 treatment</a>&nbsp;&nbsp;<font color="#6f6f6f">Fierce Pharma</font>
